CIK 0000879169 · Large accelerated filer
INCYTE CORP
Sign in to watch- Ticker
- INCY
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943136539
- Phone
- 3024986700
- Business address
- 1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, 19803
- Former names
- INCYTE INC, INCYTE GENOMICS INC, INCYTE PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $28,435,748
- in 1 filing, $28.4M under 10b5-1 plans
Net −$28,435,748. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-06 | Stein Steven H CMO & Head of Late-Stage Dev. | Option exercise 10b5-1 | +8,539 | $68.62 | $586K | 39,455 |
| 2026-11-06 | Stein Steven H CMO & Head of Late-Stage Dev. | Option exercise 10b5-1 | +12,335 | $72.27 | $891K | 51,790 |
| 2026-11-06 | Stein Steven H CMO & Head of Late-Stage Dev. | Option exercise 10b5-1 | +16,428 | $80.50 | $1.3M | 68,218 |
| 2026-11-06 | Stein Steven H CMO & Head of Late-Stage Dev. | Option exercise 10b5-1 | +15,054 | $74.78 | $1.1M | 83,272 |
| 2026-11-06 | Stein Steven H CMO & Head of Late-Stage Dev. | Option exercise 10b5-1 | +23,526 | $77.67 | $1.8M | 106,798 |
| 2026-11-06 | Stein Steven H CMO & Head of Late-Stage Dev. | Option exercise 10b5-1 | +18,331 | $61.76 | $1.1M | 125,129 |
| 2026-11-06 | Stein Steven H CMO & Head of Late-Stage Dev. | Option exercise 10b5-1 | +19,749 | $61.18 | $1.2M | 144,878 |
| 2026-11-06 | Stein Steven H CMO & Head of Late-Stage Dev. | Option exercise 10b5-1 | +12,305 | $64.25 | $791K | 157,183 |
| 2026-11-06 | Stein Steven H CMO & Head of Late-Stage Dev. | Option exercise 10b5-1 | +6,907 | $68.25 | $471K | 164,090 |
| 2026-11-06 | Stein Steven H CMO & Head of Late-Stage Dev. | Option exercise 10b5-1 | +16,428 | $85.01 | $1.4M | 180,518 |
| 2026-11-06 | Stein Steven H CMO & Head of Late-Stage Dev. | Option exercise 10b5-1 | +12,743 | $90.56 | $1.2M | 193,261 |
| 2026-11-06 | Stein Steven H CMO & Head of Late-Stage Dev. | Option exercise 10b5-1 | +15,054 | $83.58 | $1.3M | 208,315 |
| 2026-11-06 | Stein Steven H CMO & Head of Late-Stage Dev. | Option exercise 10b5-1 | +24,838 | $83.20 | $2.1M | 233,153 |
| 2026-11-06 | Stein Steven H CMO & Head of Late-Stage Dev. | Option exercise 10b5-1 | +879 | $113.64 | $100K | 234,032 |
| 2026-11-06 | Stein Steven H CMO & Head of Late-Stage Dev. | Option exercise 10b5-1 | +17,986 | $113.64 | $2.0M | 252,018 |
| 2026-11-06 | Stein Steven H CMO & Head of Late-Stage Dev. | Option exercise 10b5-1 | +19,091 | $113.64 | $2.2M | 271,109 |
| 2026-11-06 | Stein Steven H CMO & Head of Late-Stage Dev. | Sale 10b5-1 | −35,042 | $116.06 | $4.1M | 236,067 |
| 2026-11-06 | Stein Steven H CMO & Head of Late-Stage Dev. | Sale 10b5-1 | −22,336 | $117.15 | $2.6M | 213,731 |
| 2026-11-06 | Stein Steven H CMO & Head of Late-Stage Dev. | Sale 10b5-1 | −60,270 | $118.27 | $7.1M | 153,461 |
| 2026-11-06 | Stein Steven H CMO & Head of Late-Stage Dev. | Sale 10b5-1 | −73,969 | $119.12 | $8.8M | 79,492 |
Page 1 of 2 · 37 trades